Hua Medicine (Shanghai) Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was CNY 325.73 million compared to CNY 393.13 million a year ago. Basic loss per share from continuing operations was CNY 0.34 compared to CNY 0.41 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 HKD | -1.24% | -1.85% | -19.29% |
03-28 | Hua Medicine Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Hua Medicine Ltd. Appoints Yi Zhang as Executive Director with Effect from January 1, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.29% | 199M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- 2552 Stock
- News Hua Medicine (Shanghai) Ltd.
- Hua Medicine Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021